Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 196,450 shares of common stock and 56,400 restricted stock units to be distributed among 13 new employees with a grant date of May 1, 2020.